Silencing of the TGF-β1 Gene Increases the Immunogenicity of Cells From Human Ovarian Carcinoma

Journal of immunotherapy (Hagerstown, Md. : 1997) - United States
doi 10.1097/cji.0b013e31824d72ee
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)


Related search